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In the inﬂammosome complex, NALP3 or NALP1 binds to ASC and activates caspase-1 which induces IL-1β. In murine LPS-
induced ocular inﬂammation, the production of IL-1β is increased. We suggest that NALP3- or NALP1-inﬂammasome complex
can be participating in the LPS-induced ocular inﬂammation. In this work, eye, brain, testis, heart, spleen, and lung were obtained
from C3H/HeN mice treated with LPS for 3 to 48 hours, and the expression of NALP1b, NALP3, ASC, caspase-1, IL-1β, and IL-18
was determined. Inﬁltrated leukocytes producing IL-1β in the anterior chamber were found at 12-hour posttreatment. A high
upregulated expression of NALP3, ASC, caspase-1, IL-1β, and IL-18 was found at the same time when inﬁltrated leukocytes were
observed. NALP1b was not detected in the eye of treated mice. NALP3 was also overexpressed in heart and lung. These results
suggest that NALP3-, but not NALP1-inﬂammosome complex, is participating in the murine LPS-induced ocular inﬂammation.
Copyright © 2008 Jos´ eF .G o n z´ alez-Ben´ ıtez et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
The innate immunity is the ﬁrst barrier in the protection
against ocular infections. The Toll-like receptors (TLRs),
that belong to pattern recognition receptors (PRRs) family,
have been the molecules involved in the recognition of
pathogen-associated molecular patterns (PAMPs) that lead
to ocular inﬂammatory process. Nevertheless, other PRRs
such as Nod-like receptor (NLR) could also be participating
in this phenomenon. The human genome database reveals
that NLR family consist of at least 22 genes. Alternative
names for this family include CATERPILLER, NOD, and
NOD-LRR. The NLRs have three structural domains, LRR
domain (carboxy-terminal), an intermediary NACHT (NBS;
NOD) domain, and an eﬀector domain (amino-terminal),
which can be a pyrin domain (PYD), a caspase recruitment
domain (CARD), or a baculovirus inhibitor of apoptosis
protein repeat (BIR) domain [1].
Based on the phylogenetic history of NACHT domain
(which is only present in NLR), and on the particular type
of eﬀector domain, the 22 NLR family members can be
classiﬁed in two large subfamilies: the NODs (NLR family,
CARD domain containing) also called NLRCs, and the
NALPs (NLR family, pyrin domain containing) also called
NLRPs. Through genomic database searches, 14 NALPs
members have been identiﬁed in the human genome [1, 2].
As NALPs have been recently discovered, the participation
of these molecules in the ocular inﬂammation remains
unknown.
One well-established feature of NALPs is their ability to
interact with apoptosis-associated speck-like protein (ASC)
throughaPYD-PYDinteraction.ASCencodesa22-kDapro-
tein that contains a carboxy-terminal CARD and an amino-
terminal PYD, suiting as an adaptor molecule between PYD-
and CARD-containing proteins. An interaction between
ASC and NALPs was shown initially for NALP1 (Nlrp1/
DEFCAP/NAC/CARD7) and subsequently also found for
NALP2 and NALP3 (Nlrp3/PYPAF1/Cryopyrin/CIAS1). The
PYD of ASC interacts with the PYD of several NALPs,
whereas ASC’s CARD recruits the CARD of procaspase-1
for its activation [3, 4] .T h ea c t i v ec a s p a s e - 1w a sf o u n dt o
be required for the production of active IL-1β and IL-18 in2 Mediators of Inﬂammation
activated macrophages and monocytes [5]. When NALP and
ASC interact with activate caspase-1 or caspase-5, they create
an intracellular complex termed inﬂammosome [1, 2].
More than one type of inﬂammasomes have been
identiﬁed up to date. NALP1-inﬂammasome is composed
of NALP1, ASC, caspase-1, and caspase-5, whereas the
NALP2/3-inﬂammasomes contain NALP2 or NALP3, ASC
and caspase-1. A fourth inﬂammasome is composed of
IPAF, ASC, and caspase-1 [1, 2]. NALP12 does not form
inﬂammasome complex but it participate in inﬂammation
as a negative regulator interfering with IRAK-1 function,
resulting in the repression of TLR signalling [6].
LPS-induced ocular inﬂammation is a model to study
molecular mechanisms involved in murine uveitis, where
the expression of proinﬂammatory cytokines such as IL-
1β,T N F α, and IL-6 is present [7]. We suggest that an
inﬂammasomecomplexcouldbeparticipatinginthemurine
LPS-induced ocular inﬂammation. In this work, mRNA
expressionofNALP1b,NALP3,NALP12,ASC,caspase-1,IL-
6,TNFα, IL-18, and IL-1β intheeyeofmicetreatedwithLPS
was studied.
2. MATERIALS AND METHODS
2.1. Mousestrain
C3H/HeN mice (Harlan, Mexico City, Mexico) susceptible
to ocular inﬂammation by endotoxin were used. All mice
were healthy, 6–8 weeks old, and did not present any
ophthalmologic alteration. All mice were maintained in
aseptic conditions during the treatment.
The experimental protocols were performed in accor-
dancetotheInstitutoPolit´ ecnicoNacionalstatementsforthe
use of animals in research.
2.2. LPS-inducedocularinﬂammation
To generate LPS-induced ocular inﬂammation, C3H/HeN
mice received a footpad injection of 200μgo fEscherichia coli
K-235 LPS (Sigma Chemical Company, Mo, USA) in 50μL
of phosphate-buﬀered saline solution (PBS). The mice were
killed by cervical dislocation at 3, 6, 12, 24, and 48 hours
posttreatment and the eye, brain, testis, heart, spleen, and
lung were obtained from each mouse. As control, ﬁve mice
received a footpad injection of 50μL sterile PBS and killed
after 48 hours. Groups of 5 treated mice were included in
each time of treatment. From each mouse, one eye was ﬁxed
in formaldehyde for histology analysis and the other one was
treatedwithTrizol(Invitro,Carlsbad, Calif,USA)reagentfor
RT-PCR analysis.
2.3. Histologicalanalysis
To verify if inﬁltration of leukocytes in the eyes of treated
mice occurred, ﬁxation of the whole eye in buﬀered
formaldehyde (3.5g NaH2PO4 anhydrous, 6.5g NaH2PO4,
and 40% formaldehyde) was carried out and embedded
in paraﬃn. Sections of 3μm slides were stained with
haematoxylin-eosin. For quantiﬁcation of inﬁltrated cells,
the observed cells per ﬁeld of view (40X) were counted, and
the mean value was reported.
2.4. Immunohistochemicalanalysis
The immunohistochemical analysis was developed in 3.0μm
sections of ocular and testis tissues ﬁxed with buﬀered
formaldehyde. Rabbit polyclonal IgG antimouse IL-1β
(Santa Cruz Biotechnology, Santa Cruz, Calif, USA) and
irrelevant rabbit IgG (Santa Cruz Biotechnology) were used
to assess expression of the proteins, followed by a secondary
biotinylated antibody and streptavidin/peroxidase complex
(LSAB+ Kit peroxidase, Dako Cytomation, Carpinteria,
Calif, USA), and visualized with TACS-Blue Label (R&D
System, Minn, USA) as chromogen and counterstained with
Nuclear Fast Red counterstain (Sigma-Aldrich, Mo, USA).
2.5. RNAisolationandRT-PCRanalysis
All studied organs were thoroughly washed in D-PBS to
eliminate blood. Total RNA extraction was performed with
TRIzol reagent and treated with DNAse I free of RNAse.
For reverse transcriptase (RT) reaction, total RNA (3μg)
and 0.5μg of oligo-(dT)15-18 (Invitrogen) were denatured at
70◦C for 10 minutes, and 1X single strand buﬀer, 0.5mM
DTT, 500μM of each dNTPs, and 200U of MMLV reverse
transcriptase (Invitrogen, Ohio, USA) were added. The RT
reactions were performed at 42◦Cf o r1h o u r .T h eP C R
reactions were prepared with 1μL of the cDNA, 1X buﬀer,
1mM MgCl 2, 200μMo fe a c hd N T P s ,1 Uo fT a q D N A
polymerase, and 0.2μM of each NALPs, ASC, caspase-1,
IL-1β, IL-18, and β-actin primers (see Table 1). Optimal
PCR conditions were 30 cycles of 92◦C 30 seconds, 60◦C3 0
seconds, and 72◦C 30 seconds.
To semiquantitate PCR products, the intensity of the
ampliﬁed bands was analyzed with the AlphaImager soft-
ware. Band intensities were normalized with the correspond-
ing β-actin signal, and relations NALPs/β-actin, ASC/β-
actin, caspase-1/β-actin, and interleukines/β-actin were cal-
culated. The results were analyzed by Kruskal-Wallis and
Turkey statistical tests.
3. RESULTS
3.1. Analysisofocularinﬂammationin
micetreatedwithLPS
Histological and molecular analyses were done to evaluate
the ocular inﬂammation of mice treated with LPS, therefore
leukocytes inﬁltrated in the anterior chamber and proin-
ﬂammatory cytokines expression were determinated. In the
eyes of LPS-treated mice, there were leukocytes inﬁltrated in
the anterior chamber from 3 to 48 hours of treatment (see
Figure 1(a)) and at 12 hours the mean value of inﬁltrated
leukocytes was the highest (ten cells per ﬁeld; P<. 05; see
Figure 1(b)).
To conﬁrm ocular inﬂammation in the eye of treated
mice, the mRNA expression of the proinﬂammatory
cytokines IL-6 and TNFα was determined. IL-6 mRNA wasJos´ eF .G o n z´ alez-Ben´ ıtez et al. 3
Table 1: Sequence of oligonucleotides.
Gene Sequence Size ampliﬁed (pb)
β-Actin Fw: 5 -TGGAATCCTGTGGCATCCATGAAAC-3 
324
Rv: 5 -TAAAACGCAGCTCAGTAACAGTCCG-3 
NALP3 Fw: 5 -CTGTGTGTGGGACTGAAGCAC-3 
544
Rv: 5 -GCAGCCCTGCTGTTTCAGCAC-3 
NALP1b Fw: 5 -TGGGATGGTTCTAGAAACGCC-3 
602
Rv: 5 -AGGGTCCACTGATGTCACTCG-3 
NALP5 Fw: 5 -CCTGAGGAATCCAGAATGTGC-3 
238
Rv: 5 -GCTTCCACAGGCCAATTATCC-3 
NALP12 Fw: 5 -GTACCAACTCCAACCTGATCG-3 
512
Rv: 5 -GAAGTAGAGGCCAGATCTTTGC-3 
ASC Fw: 5 -AGACATGGGCTTACAGGA-3 
257
Rv: 5 -CTCCCTCATCTTGTCTTGG-3 
Caspase-1 Fw: 5 -TGAAAGAGGTGAAAGAATT-3 
424
Rv: 5 -TCTCCAAGACACATTATCT-3 
IL-1β Fw: 5 -TGGGCCTCAAAGGAAAGA-3 
157
Rv: 5 -GGTGCTGATGTACCAGTT-3 
IL-18 Fw: 5 -CTGTACAACCGCAGTAATACGG-3 
264
Rv: 5 -ACTCCATCTTGTTGTGTCCTGG-3 
IL-6 Fw: 5 -TCTCTGGGAAATCGTGGAAAT-3 
308
Rv: 5 -TGTATCTCTCTGAAGGACTCTG-3 
TNFα Fw: 5 -CCTCCCTCTCATCAGTTCTATGG-3 
238
Rv: 5 -TGTCCCTTGAAGAGAACCTGG-3 
highly expressed in LPS-treated mice and semiquantitative
analysis showed a signiﬁcant increase of IL-6 at 3, 6, and
12 hours posttreatment (see Figure 1(c)). In treated mice,
the highest expression of TNFα mRNA was observed at 12
hours (see Figure 1(c)). At this time, it was also observed
that the inﬁltrated leukocytes were producing and secreting
IL-1β (see Figure 1(d)). These results demonstrate that LPS
induced ocular inﬂammation.
3.2. ExpressionanalysisofNALP1bandNALP3in
micetreatedwithLPS
To analyse the type of inﬂammasome complex present in
the eye of treated mice, expression of NALP1b and NALP3
was determined. NALP1b mRNA was not found, neither in
the eye of the treated mice, nor in controls (see Figure 2).
In contrast, NALP3 expression was detected in the eye of
treated mice, and its highest expression was observed at
12 hours posttreatment (P<. 05; see Figure 2). These
results demonstrate that there is a diﬀerential expression of
NALP1b and NALP3 in the LPS-induced ocular inﬂamma-
tion.
In the other studied organs, NALP3 mRNA was detected
in heart (from 3 hours posttreatment) and lung (from 6
hours posttreatment) but not in testis, brain, and spleen (see
Figure 3). Although the highest NALP3 expression occurred
in the eye at 12 hours posttreatment, NALP3 arose earlier in
heart and lung (3 and 6 hours, resp.).
3.3. ExpressionanalysisofASC,caspase-1,IL-1β,
andIL-18intheeyeofLPS-treatedmice
As NALP3 expression occurred in the eye, and as an increase
of its expression was induced by LPS, the expression of the
other inﬂammasome components (ASC, caspase-1, IL-1β,
and IL-18) in this organ was determined. The ASC mRNA
expression was observed in both nontreated and treated
mice but the highest expression was found at 12 hours
posttreatment (see Figure 4). The expression of caspase-1
was gradually increased from 3 hours, and at 12 hours it
showed its highest expression (see Figure 4). The expression
of IL-1β was upregulated from 3 hours posttreatment, and
its highest expression happened at 12 hours posttreatment as
occurred with the protein (see Figures 4 and 1(d)). Similar
results were observed for the IL-18 expression (see Figure 4).
3.4. ExpressionofNALP12(Monarch1)andNALP5in
theeyeLPS-treatedmice
As NALP12 (Monarch 1) is a molecule that can negatively
regulate the inﬂammasome complex, the participation of
this molecule in the LPS-induced ocular inﬂammation was
investigated. A slight induction in the expression of NALP12
due to LPS-treatment was observed at 12 and 24 hours, but
without statistical relevance (P>. 05; see Figure 5(a)).
To assess if the LPS treatment can also modify the
expression of other NALPs that are not involved in the
inﬂammasome complex, such as NALP5, the expression4 Mediators of Inﬂammation
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Figure 1: Histological and molecular analysis of the LPS-induced ocular inﬂammation. C3H/HeN mice were inoculated in the footpad with
200μg/50μL of LPS and the inﬂammation was analyzed at 3, 6, 12, 24, and 48 hours. Control mice (C) received a footpad injection of 50μL
of sterile PBS. (a) histological analysis of leukocyte inﬁltration in the anterior chamber stained with hematoxylin-eosin (40x). The arrows
point inﬁltrated cells. The ﬁgure shows a representative result of ﬁve mice studied in each time. (b) average of inﬁltrated leukocytes observed
in (a). (c) average of semiquantitative analysis of IL-6 and TNFα mRNA expression. Asterisk indicates signiﬁcant diﬀerence compared with
the control (P<. 05) analyzed by Kruskal-Wallis and Turkey tests. (d) ocular expression of IL1β protein in treated and untreated mice.
Immunostaing of IL-1β of untreated mouse (I) and treated mice at 12 hours posttreatment (II and III). (e) testis tissue was used as positive
control of IL1β expression; irrelevant antibody (I), IL-1β antibody (II). Blue staining means positive signal.
of this molecule was determinated. The eye of untreated
mice did not express NALP5, and the LPS induced slight
expression of it at 12 hours posttreatment, but again without
statistical relevance (P>. 05; see Figure 5(b)).
4. DISCUSSION
In this work, we observed that LPS induced the mRNA
expression of IL-1β,I L - 6 ,T N F - α,a n dI L - 1 8a sw e l la st h e
secretionofIL-1β bytheleukocyteinﬁltrationintheanterior
chamber of the eye, conﬁrming an ocular inﬂammation
process. Therefore, we searched if the expression of NALP3,
NALP1b, ASC, and caspase-1 correlates with the expression
of IL-1β and IL-18 in the LPS-induced ocular inﬂammation
model.
NALP3 forms a multiprotein complex called “inﬂam-
masome,” which contains ASC and caspase-1, and this
complexpromotescaspase-1activationandconsequentlytheJos´ eF .G o n z´ alez-Ben´ ıtez et al. 5
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Figure 2: Semiquantitative analysis of NALP3 and NALP 1b mRNA
expression in the eye of LPS-treated mice. Mice were treated with
LPS during 3, 6, 12, 24, and 48 hours. NALP3 and NALP1b
mRNA expressions were determined by RT-PCR. Average of 5
mice analyzed in each assayed time is reported. Asterisk indicates
signiﬁcant diﬀerence compared with the control (P<. 05) analyzed
by Kruskal-Wallis and Turkey tests.
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Figure 3: Semiquantitative analysis of NALP3 mRNA expression
in the eye, heart, lung, testis, brain, and spleen of LPS-treated mice.
NALP3mRNAexpressionwasdeterminedbyRT-PCRintheorgans
of mice treated with LPS during 3, 6, 12, 24, and 48 hours. Average
of 5 mice analyzed in each assayed time is reported. Asterisk
indicates signiﬁcant diﬀerence compared with control (P<. 05)
analyzed by Kruskal-Wallis and Turkey tests.
processing of pro-IL-1β and IL-18 in macrophages cultures
[2]. We found that the NALP3 mRNA expression was
increased in the eye of mice treated with LPS at 12 hours.
The expression of NALP1b was found neither in treated nor
in control mice, suggesting that the NALP3-inﬂammosome
complex, but not the NALP1b-inﬂammosome complex,
could be associated with the LPS-induced ocular inﬂamma-
tion. The NALP3 expression has been documented predom-
inantly in monocytes, granulocytes, and chondrocytes [8].
The murine NALP3 mRNA expression was found initially in
peripheral blood leukocytes, consistent with the postulation
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Figure 4: Expression analysis of NALP3-inﬂammasome components
in the eye of LPS-treated mice. Semiquantitative RT-PCRs were
performed for the analysis of NALP3, ASC, caspase-1, IL-1β,a n d
IL-18 expression in the eye of LPS-treated mice. Average of 5
mice analyzed in each assayed time is reported. Asterisk indicates
signiﬁcant diﬀerence compared with the control (P<. 05) analyzed
by Kruskal-Wallis and Turkey tests.
of an inﬂammatory function. NALP3 has also been detected
in the eye and skin of healthy mouse [9]. Nevertheless, this
is the ﬁrst report that shows the increase of the NALP3
expression in the LPS-induced ocular inﬂammation. It is
important to highlight that the overexpression of NALP3
correlated with the time leukocytes was found inﬁltrated
producing IL-1β. In vitro studies have demonstrated that
primary human monocytes stimulated with LTA, LPS, or
poly(I:C) elicited a robust induction of NALP3 expression
[10]. With our results, we show that LPS can induce in vivo
the expression of NALP3 in the eye.
This is also the ﬁrst report that shows that LPS induces
the expression of NALP3 in heart and lung but not in spleen,
neverthelessithasbeenreportedthatNALP3isnotexpressed
in lymphoid and skin tissues of healthy mouse [11]b u t
that NALP1 does. Chu et al. reported that NALP1 mRNA is
expressed in healthy organs, such as heart, thymus, spleen,
kidney, liver, lung, and peripheral blood lymphocytes [12];
we are reporting that NALP1 is not expressed in the eye of
healthy mice, but even after treatment with LPS it remains
absent.
We found that the expression of NALP3 in the eye is
delayed respect heart’s and lung’s. About it, we suggest that
the hemato-ocular barrier that could delay the LPS arrival to
the ocular tissues interfering in the time NALP3 is induced.
The early expression of NALP3 in heart and lung could
contribute to the eﬀect of septic shock by LPS.
NALP3-deﬁcient mice have been generated to investigate
the role of NALP3 in inﬂammatory responses to pathogen-
derived molecules. NALP3-deﬁcient macrophages do not
produce active IL-1β in response to LPS, Pam3 CSK4 (TLR2
agonists), Staphylococcus aureus, Listeria monocytogenes [13],
bacterial RNA, and the imidazoquinoline compounds R837
and R848 (TLR7 and TLR8 agonists) [14]. Nevertheless,6 Mediators of Inﬂammation
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Figure 5: Semiquantitative analysis of NALP12 and NALP5 mRNA expression in the eye LPS-treated mice. NALP12 (panel (a)) and NALP5
(panel (b)) mRNA expression were determined by RT-PCR. Mice were treated with LPS during 3, 6, 12, 24, and 48 hours. Average of 5 mice
analyzed in each assayed time is reported. Analysis of Kruskal-Wallis test showed no statistical signiﬁcance.
NALP3-deﬁcient macrophages, but not the IPAF-deﬁcient
macrophages, can produce IL-1β when stimulated with
Salmonella. On the other hand, ASC-deﬁcient macrophages
do not produce IL-1β with any of the TLR agonists and cited
bacteria. These results indicate that the adaptor ASC is the
principal molecule for both NALP- and IPAF-inﬂammasome
complexes [4, 15]. ASC is abundantly expressed in epithelial
cells, leukocytes, hair follicles, and peripheral blood lympho-
cytes [16], and in neutrophils located in severe inﬂammatory
sites [17]. In the eye, we found that ASC is expressed, and
that the LPS can increase its expression.
Caspase-1 is another component of the inﬂammasome
complex useful for the activation of IL-1β. Caspase-1-
deﬁcient mice carry a defect in the production of mature
IL-1β after stimulation with LPS. Furthermore, these mice
are resistant to endotoxic shock [18]. Bacterial RNA can also
induce the activation of caspase-1 trough NALP3 [14]. We
found that caspase-1 was increased in the eyes of the mice
treated with LPS at the same time when NALP3, ASC, IL-
1β, and IL-18 showed their highest expression (at 12 hours).
These results suggest that the high expression of NALP3,
caspase-1, ASC, IL-1β, and IL-18 could be participating in
the murine LPS-induced ocular inﬂammation.
In this report, we also analyzed the NALP12 expression
in LPS-induced ocular inﬂammation. Although a slight
increase in the expression of NALP12 in the eyes of treated
mice was detected, statistically it was not relevant. This
suggests that this molecule does not participate in the
regulationoftheLPS-inducedocularinﬂammationasoccurs
in monocytes and granulocytes stimulated with TNFα and
other TLRs ligands [6].
NALP5 has not been involved in the inﬂammasome
complex, but it has been related to reproduction because it
has been detected in oocytes [19, 20]. So far, there are no
reports about the expression of NALP5 in the eye. Although
we did not ﬁnd NALP5 expressed in the eye of the control
mice, we found it barely detectable in some eyes of treated
mice.
In summary, these results suggest that LPS induced a
signiﬁcant expression of NALP3-inﬂammasomme complex
in the endotoxin-induced ocular inﬂammation.
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